Pancreatic Cancer Research

ResearcherUniversity Hospital HeidelbergActive in the last 2 years

Manuel Röhrich

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7609-243X; OpenAlex author ID A5068074709. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. Carbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT04194268). Co-author DOI 10.1016/j.radonc.2026.111836↗
  2. Immunohistochemical FAP Expression Reflects 68Ga-FAPI PET Imaging Properties of Low- and High-Grade Intraductal Papillary Mucinous Neoplasms and Pancreatic Duc… Last author DOI 10.2967/jnumed.123.266393↗
  3. Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Recurrent Pancreatic Cancer. Co-author DOI 10.3390/cancers13040796↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Patrick Naumann · 2 shared papers, 2021–2026 · strength 0.34
  2. Jakob Liermann · 2 shared papers, 2021–2026 · strength 0.34
  3. Klaus K Herfarth · 2 shared papers, 2021–2026 · strength 0.34
  4. Jürgen Debus · 2 shared papers, 2021–2026 · strength 0.34
  5. Christoph Michalski · 1 shared paper, 2026 · strength 0.23
  6. Andrea Mairani · 1 shared paper, 2026 · strength 0.23
  7. Semi Harrabi · 1 shared paper, 2026 · strength 0.23
  8. Christoph Springfeld · 1 shared paper, 2026 · strength 0.23
  9. Filipa Baltazar · 1 shared paper, 2026 · strength 0.23
  10. Thomas Moritz Pausch · 1 shared paper, 2024 · strength 0.21
  11. Thilo Hackert · 1 shared paper, 2024 · strength 0.21
  12. Anna-Maria Spektor · 1 shared paper, 2024 · strength 0.21
  13. Frederik Lars Giesel · 1 shared paper, 2021 · strength 0.11
  14. Edgar Ben‐Josef · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.